Navigation Links
Avicena Group to Present at Noble Financial Conference
Date:8/19/2007

PALO ALTO, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases announced today that Chief Executive Officer Dr. Belinda Tsao-Nivaggioli will present an overview of the company's ongoing product development programs at 1:30 EDT on August 20, 2007, at the Noble Financial Two Double-0-Seven Conference at the Charleston Place Hotel in Charleston, S.C.

The audio and slide presentation will be available on Avicena's website http://www.avicenagroup.com and Noble Financial's conference web site at http://www.two-007.net. A replay will be available at these addresses after the live presentation and will be archived for 90 days.

ABOUT AVICENA

Avicena Group, Inc. is a Palo Alto, California-based late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). The company is currently analyzing data from its Phase IIb/III trial in ALS. Near term, Avicena intends to initiate a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

Contact:

The Ruth Group (on behalf of Avicena Group)

Sara Ephraim / (investors)

(646) 536-7029 / 7002

sephraim@theruthgroup.com

Janine McCargo / Jason Rando (media)

(646) 536-7033 / 7025

jmccargo@theruthgroup.com / jrando@theruthgroup.com


'/>"/>
SOURCE Avicena Group

Copyright©2007 PR Newswire.

Related biology technology :

1. Cardinal Health likes growth potential of Viasys NeuroCare Group
2. Technology consulting group adds Sanders
3. CIO Leadership Series: Kathi Christian, QTI Group
4. CEO of healthcare group still hopeful IT will save employers money
5. California group says ruling weakens WARFs stem cell patent
6. Instant messaging comes to groups
7. Midwest plays small role in VC investment, angel groups to the rescue
8. Group promoting classified research elects officers
9. Milwaukee regional development group agrees on name
10. Local group building Dane County economic development corp.
11. Bruker AXS to acquire companies, form Microanalysis Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2020)... , ... March 03, 2020 , ... ... the pharmaceutical, biotech and medical device industries, was recognized by INC. 5,000 on ... forward annual lists to note industry leaders greatly impacting their spheres of influence ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik IP, LLC ... the field of Biotechnology and Organics. , According to statistics compiled by Harrity Anaytics, ... patents issued in technology center 1600 during 2019. Technology center 1600 at the US ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing ... recently published the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose ... in human milk. These complex carbohydrates are indigestible and therefore function as a ...
(Date:2/21/2020)... ... February 20, 2020 , ... ... elegant chemistry. Humans have been increasingly successful in innovating ways to engineer ... evolving technologies and strategies for modern molecular biology (e.g., gene sequencing, writing, ...
Breaking Biology Technology:
(Date:3/11/2020)... , ... March 11, 2020 , ... ... telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces a ... 100,000 people in over 100 countries and has caused over 4,000 fatalities to ...
(Date:3/9/2020)... ... March 09, 2020 , ... ... rate of 64% last year, as enterprises sought to achieve competitive advantage ... Unfortunately, only 13% of all transformation efforts delivered the intended consequences. , ...
(Date:3/5/2020)... ... ... Patients in need of new teeth after tooth extraction or full mouth tooth ... Ocala. Same-day dental implants allow patients with an entire mouth of missing ... treatment utilizes advanced technology and Dr. Brand’s unique experience and skills to provide life ...
Breaking Biology News(10 mins):